Brainstorm Cell Therapeutics Inc. (BCLI)

NASDAQ: BCLI · IEX Real-Time Price · USD

0.353

-0.004 (-1.12%)

At close: Jul 2, 2024, 4:00 PM

0.358

+0.005 (1.30%)

After-hours: Jul 2, 2024, 7:50 PM EDT

BCLI Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018 - 2007
Net Income	-17.19	-24.28	-24.46	-31.81	-23.25	Upgrade
Depreciation & Amortization	0.27	0.29	0.26	0.22	0.16	Upgrade
Share-Based Compensation	1.49	1.68	1.37	2.56	0.76	Upgrade
Other Operating Activities	-5.02	2.99	-3.43	-6.16	11.08	Upgrade
Operating Cash Flow	-20.46	-19.32	-26.27	-35.19	-11.25	Upgrade
Capital Expenditures	-0.02	-0.03	-0.33	-0.38	-0.47	Upgrade
Change in Investments	2.21	1.03	0.65	-4.07	6.09	Upgrade
Investing Cash Flow	2.19	1	0.32	-4.45	5.62	Upgrade
Share Issuance / Repurchase	18.98	0.24	6.97	76.94	5.23	Upgrade
Financing Cash Flow	18.98	0.24	6.97	76.94	5.23	Upgrade
Net Cash Flow	0.71	-18.08	-18.97	37.29	-0.41	Upgrade
Free Cash Flow	-20.48	-19.35	-26.6	-35.57	-11.72	Upgrade
Free Cash Flow Per Share	-0.47	-0.53	-0.73	-1.19	-0.54	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).